NEUCLONE

NeuClone is a clinical-stage biopharmaceutical company with an exclusive focus on the development and commercialisation of high quality biosimilar products... Led by a team of industry veterans, we are focused on creating a deep pipeline of high quality biosimilars at a scale and price that meets demands of global markets. NeuClone is differentiated by this unmatched pipeline, and a trademark Right From the Start® approach - through which we continually confirm biosimilarity at the earliest stages and throughout development.

Also known as: NeuClone Pty Ltd.

Registration numbers: 56 123 989 659 (W)